000			03621nam a2200205Ia 4500
008			250806s9999||||xx |||||||||||||| ||und||
020			_a9780849390067 (hardcover : alk. paper);0849390060 (hardcover : alk. paper)
060			_aQV 744 _b.C44 2008
245		0	_aChemistry and molecular aspects of drug design and action / _c[edited by] E.A. Rekka, P.N. Kourounakis.
260			_aBoca Raton : _bCRC Press, _cc2008.
300			_axxii, 356 p. : _bill.
504			_aIncludes bibliographical references and index.
505			_aInflammatory mechanisms in Alzheimer's disease and other neurodegenerative disorders / Joseph Rogers ... [et al.] -- Treatment development strategies for Alzheimer's disease / Ernst Wu??lfert -- Lipoprotein-associated phospholipase A2 as a new prognostic factor for coronary artery disease / Alexandros D. Tselepis -- New molecular targets for the prevention and treatment of gastrointestinal ulcers and inflammation / Sandor Szabo ... [et al.] -- Stress activates corticotropin releasing factor signaling pathways : implication in functional bowel disorders / Yvette Tache?? -- Design, synthesis, and pharmacological evaluation of high-affinity and selectivity sigma-1 and sigma-2 receptor ligands / Jacques H. Poupaert -- Synthesis of biologically active taxoids / K.C. Nicolaou and R.K. Guy -- From the molecular pharmacology to the medicinal chemistry of cannabinoids / Didier M. Lambert -- An appraisal of fomocaines : current situation and outlook / Herbert Oelschla??ger and Andreas Seeling -- Ligands for the GABA recognition site at the GABAA receptor : structure-activity studies / Bente Fr??lund ... [et al.] -- Strategies for development of new lead structures for inhibition of acetylcholinesterase / Petra Kapkova ... [et al.] -- Discovery of potent and selective inhibitors of human aldosterone synthase (CYP11B2) : a new target for the treatment of congestive heart failure and myocardial fibrosis : a review / R.W. Hartmann ... [et al.] --;Thiocarboxanilides : a new class of nonnucleoside reverse transcriptase inhibitors (NNRTIS) with great potential for the treatment of human immunodeficiency virus type 1 (HIV-1) infections / E. De Clercq, A. Karlsson, and J. Balzarini -- Histamine H3-receptor agonists and antagonists : chemical, pharmacological, and clinical aspects / Holger Stark and Walter Schunack -- Anti-inflammatory actions of flavonoids and structural requirements for new design / Theoharis C. Theoharides -- Molecular mechanisms of H2O2-induced DNA damage : the action of desferrioxamine / M. Tenopoulou, P.-T Doulias, and D. Galaris -- LNA (locked nucleic acid) and functionalized LNA : toward efficient gene targeting / Jesper Wengel -- The effect of diet on drug metabolism / K.J. Netter -- Cytochromes P450 in the metabolism and bioactivation of chemicals / Costas Ioannides -- In vitro methods to measure drug metabolism and drug interactions in drug discovery and development / O. Pelkonen ... [et al.] -- How to probe the sites of action of drug molecules / A. Makriyannis and F. Bitter -- Physicochemical profiling in early drug discovery : new challenges at the age of high-throughput screen and combinatorial chemistry / Bernard Fuller -- Drug-membrane interaction and its importance for drug efficacy / J.K. Seydel ... [et al.] -- The fight against AIDS : new avenues for inhibiting reverse transcriptase (RT), an old target / Maurizio Botta ... [et al.].
650			_aChemistry, Pharmaceutical
650			_aDrug Design
650			_aPharmacological Phenomena
700			_aKourounakis, P. N.
700			_aRekka, E. A.
942			_bDIMC _cBK
999			_c25730 _d25730